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Monocytes on
the Scar’s Edge*
Stefan Frantz, MD, Ulrich Hofmann, MD
Würzburg, Germany
During the last decades, intensive investigation has revealed
diverse pathophysiological mechanisms of adverse remodel-
ing after myocardial infarction (MI), leading to several
therapeutic approaches in clinical care of patients after MI.
As a consequence, improved clinical management has sig-
nificantly lowered morbidity and mortality. Despite major
advances in pharmacological treatment of remodeling, such
as the introduction of angiotensin-converting enzyme in-
hibitors (1) and beta-blockers (2), patients surviving an MI
are still facing the development of heart failure. Most basic
and clinical science heart failure studies have focused so far
on the remodeling phase, neglecting the importance of early
wound healing after MI for the development of a competent
infarct scar and subsequently for clinical outcome. Thus, a
better understanding of healing processes has the potential
to identify novel targets for clinical intervention after MI.
See page 153
Healing after MI occurs in different phases. In the first
phase, necrotic cells are removed and capillary-rich granu-
lation tissue is formed de novo. This process is associated
with a dense infiltration of neutrophil granulocytes and
so-called “inflammatory” monocytes identified in the mouse by
high surface expression of Ly6C, the monocyte chemoattractant-
1 receptor, chemokine (C-C motif) receptor 2, or the
adhesion molecule L-selectine (CD62L). These monocytes
express both proteases and proinflammatory cytokines. The
initial “proinflammatory” phase is followed by formation of
a collagenous scar during the following weeks. In parallel,
monocyte recruitment to the infarct zone switches from
“proinflammatory” to “anti-inflammatory” differentiated cells
defined by low expression of the previously mentioned
surface molecules (3). These anti-inflammatory monocytes are
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tion of factors like vascular endothelial growth factor and
transforming growth factor-beta.
The biphasic sequence of monocyte recruitment is a prereq-
uisite for proper wound healing (e.g., a sustained Ly6Chigh
monocytosis worsens myocardial repair in apoE/ mice [4]).
Importantly, analogous to murine data, human monocyte
subsets that were defined by the surface expression pattern of
CD14 and CD16 also correlate with clinical outcome. Tsu-
jioka et al. (5) found that peak levels of the “inflammatory”
CD14 CD16 subset correlated negatively with recovery
f left ventricular (LV) function 6 months after MI. This
roup also demonstrated that enhancement of CD14
CD16 monocytes after reperfusion was associated with
microvascular obstruction in patients with ST-segment
elevation myocardial infarction (6). The absence of micro-
vascular obstruction was significantly associated with im-
provement in LV ejection fraction. Hence, interaction of
proinflammatory monocytes with endothelium might im-
pair the perfusion of small myocardial vessels and could thus
offer a possible explanation for the association of monocyte
subsets and clinical outcome.
For a long time, macrophages have been known to
critically influence the wound-healing process after MI (7).
Tissue macrophages were thought to be the major source;
however, we now know that after MI, monocytes that
invade the myocardium are released from bone marrow by
chemokine signals and especially from the spleen in re-
sponse to angiotensin (8). This leads to some confusion as
to whether cells formerly named macrophages are different
than the recently described infiltrating monocytes. We
believe this is mainly a matter of terminology because
Nahrendorf’s studies (8) demonstrated that most macro-
phages/monocytes found in the infarcted myocardium dur-
ing the early phase after MI are derived from monocytes
that were recruited from the blood. The fate of infiltrating
monocytes has not been definitively described; however, on
the basis of the current literature, one has to assume that
most of the cells that were formerly named macrophages are
directly related to infiltrating monocytes. Once recruited to
the injured myocardium, they can further differentiate into
macrophages or dendritic cells.
In this issue of the Journal, Lee et al. (9) extended the role
of monocytes early after MI both regionally and temporally.
By means of advanced imaging techniques combining 18-
fluorodeoxyglucose positron emission tomography and
magnetic resonance in mice, they demonstrated consider-
able monocyte recruitment in the remote myocardium. The
recruitment pattern was biphasic, including first Ly6Chigh
followed by Ly6Clow monocytes. Infiltration of the anti-
inflammatory Ly6Clow subset peaked approximately 5 days
ater than in the infarct zone. The imaging data were
orroborated by fluorescence-activated cell sorting pheno-
yping of the leukocyte infiltrate in the remote myocardium
f the mouse, and data from autopsy cases also showed
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cute MI. The data presented opens new perspectives in the
eld.
First, one can speculate that the function of monocytes
ecruited to the scar might be different than that of
onocytes recruited to the remote myocardium. Monocytes
f the remote myocardium might critically influence remod-
ling. Remodeling has long been associated with immune
ctivation, but the role of infiltrating leukocytes has not
een determined in detail (10). Ly6Clow monocytes espe-
ially might promote extracellular matrix turnover and
nterstitial fibrosis (e.g., by secreting factors like transform-
ng growth factor-beta and coagulation factor XIII) (11,12).
herefore, the functional role of monocyte subsets on chronic
yocardial remodeling deserves further investigation.
Second, development of a large LV infarct is a well-
nown risk factor for development of adverse remodeling in
he viable myocardium. However, remodeling also takes
lace after relatively small infarctions, but its evolution
annot be predicted. Thus, noninvasive imaging for mono-
yte infiltration might putatively allow identification of
atients at risk of developing adverse remodeling, which
ould not have been readily identified by clinical judgment.
he imaging techniques used here are feasible for use in
atients because both 18-fluorodeoxyglucose positron emis-
ion tomography and magnetic resonance imaging are
linically approved. Thus, it would be highly attractive to
dopt the technique for clinical use. Monocyte imaging
ight guide us in the future to define patient subgroups at
pecial risk that could benefit from early aggressive treat-
ent (e.g., by the initial therapy of both angiotensin-
onverting enzyme inhibitors and mineralocorticoid recep-
or blockers) despite initially preserved LV function.
However, the world has become again more complicated.
e now have to not only consider timing of different
onocyte subtypes, but also their differential spatial distri-
ution. Therapeutic interventions to improve the sequential
ecruitment of both monocyte subsets during early wound
ealing might interfere with their later recruitment in the
emote area. Thus, for translation into clinical practice, a retailed understanding of monocyte recruitment to remote
yocardium and its role for tissue remodeling are essential.
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